Cargando…
Development of Staphylococcus aureus tolerance to antimicrobial photodynamic inactivation and antimicrobial blue light upon sub-lethal treatment
Antimicrobial photodynamic inactivation (aPDI) and antimicrobial blue light (aBL) are considered low-risk treatments for the development of bacterial resistance and/or tolerance due to their multitargeted modes of action. In this study, we assessed the development of Staphylococcus aureus tolerance...
Autores principales: | Rapacka-Zdonczyk, Aleksandra, Wozniak, Agata, Pieranski, Michal, Woziwodzka, Anna, Bielawski, Krzysztof P., Grinholc, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603016/ https://www.ncbi.nlm.nih.gov/pubmed/31263139 http://dx.doi.org/10.1038/s41598-019-45962-x |
Ejemplares similares
-
Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumannii
por: Wozniak, Agata, et al.
Publicado: (2019) -
Factors Determining the Susceptibility of Bacteria to Antibacterial Photodynamic Inactivation
por: Rapacka-Zdończyk, Aleksandra, et al.
Publicado: (2021) -
Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?
por: Rapacka-Zdonczyk, Aleksandra, et al.
Publicado: (2021) -
Development of Antimicrobial Phototreatment Tolerance: Why the Methodology Matters
por: Rapacka-Zdonczyk, Aleksandra, et al.
Publicado: (2021) -
Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials–State of the Art
por: Wozniak, Agata, et al.
Publicado: (2018)